| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Monsanto Company, St. Louis, MO 63198
To establish the naturally occurring range of insulin-like growth factor-I concentrations in bovine milk, samples from individual cows (n = 409) managed on five Missouri dairy herds were assayed. Parity, stage of lactation, and farm affected milk insulin-like growth factor-I concentration. Milk insulin-like growth factor-I concentration was higher in early lactation than mid and late lactation with concentrations in multiparous cows exceeding those in primiparous cows. Insulin-like growth factor-I concentration was negatively correlated to milk production the day of sample collection (r = –.15) and not correlated to predicted 305-d milk yields.
Unprocessed bulk tank milk samples (n = 100) from a commercial processing plant had a mean concentration of insulin-like growth factor-I in milk of 4.32 ng/ml with a range of 1.27 to 8.10 ng/ml. This distribution was similar to the range detected in samples from individual cows, but values were lower than those reported for human milk. Concentration of insulin-like growth factor-I in milk was not altered by pasteurization (at 79°C for 45 s). However, insulin-like growth factor-I was undetectable in milk heated to temperatures (121°C for 5 min) required for infant formula preparation or in commercially available infant formula. These data indicated that insulin-like growth factor-I is a normal but quantitatively variable component of bovine milk that is not destroyed by pasteurization but is undetectable in infant formula. Concentration of insulin-like growth factor-I in bovine milk is lower than concentrations reported for human milk yet similar to those reported for human saliva. Farm, stage of lactation, and parity all have large effects on variability of insulin-like growth factor-I concentration of bovine milk.
Key Words: milk • insulin-like growth factor-I • parity • stage of lactation
Submitted on August 9, 1990
Accepted on March 26, 1991
This article has been cited by other articles:
|
|
 |
|
  C. Torre, I. Jeusette, M. Serra, P. Brazis, and A. Puigdemont Bovine Colostrum Increases Proliferation of Canine Skin Fibroblasts J. Nutr., July 1, 2006; 136(7): 2058S - 2060S. [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Kang, J. U. Kim, J. Y. Imm, S. Oh, and S. H. Kim The Effects of Dairy Processes and Storage on Insulin-Like Growth Factor-I (IGF-I) Content in Milk and in Model IGF-I-Fortified Dairy Products J Dairy Sci, February 1, 2006; 89(2): 402 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Parodi Dairy Product Consumption and the Risk of Breast Cancer J. Am. Coll. Nutr., December 1, 2005; 24(suppl_6): 556S - 568S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mero, J. Kahkonen, T. Nykanen, T. Parviainen, I. Jokinen, T. Takala, T. Nikula, S. Rasi, and J. Leppaluoto IGF-I, IgA, and IgG responses to bovine colostrum supplementation during training J Appl Physiol, August 1, 2002; 93(2): 732 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J Playford, C. E Macdonald, and W. S Johnson Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders Am. J. Clinical Nutrition, July 1, 2000; 72(1): 5 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. ETHERTON and D. E. BAUMAN Biology of Somatotropin in Growth and Lactation of Domestic Animals Physiol Rev, July 1, 1998; 78(3): 745 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mero, H. Miikkulainen, J. Riski, R. Pakkanen, J. Aalto, and T. Takala Effects of bovine colostrum supplementation on serum IGF-I, IgG, hormone, and saliva IgA during training J Appl Physiol, October 1, 1997; 83(4): 1144 - 1151. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
